Structured Medication Review and Shared Decision-Making in Patients with Mild Intellectual Disabilities Who Use Psychotropic Medication
Pharmacy · 06.01.2026 · 14 (1) · 5
DOI: 10.3390/pharmacy14010005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacy, online erschienen am 06.01.2026. Verfasst von Gerda de Kuijper und 2 weiteren Autor:innen. Beteiligte Einrichtung: Mental Healthcare Drenthe, Department Centre for Intellectual Disability and Mental Health, Middenweg 19, 9404 LL Assen, The Netherlands. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zorgondersteuningsfonds, P. O. box 169, 37ZK Soesterberg,.
Abstract (Originalsprache)
People with intellectual disabilities frequently use psychotropic and other medications, sometimes inappropriately. To promote shared decision-making, they require accessible information about their medication. This study combined data from two similar intervention studies, conducted in two different settings, to assess the appropriateness of medication use and the shared decision-making process among adults with mild intellectual disabilities who used psychotropic medication. The intervention consisted of a structured, multidisciplinary medication review, including the provision of accessible psychotropic medication leaflets, and a discussion of the pharmacotherapeutic treatment plan with the patient by either a pharmacist or physician, depending on the setting. Outcomes included medication use, pharmacotherapeutic problems, implementation of recommendations, and perceived shared decision-making, measured with the Shared Decision-Making Questionnaire Q9. The 15 included participants used an average of nearly seven medications, which were mainly neurotropic, gastrointestinal, cardiovascular, and respiratory agents. On average, two pharmacotherapeutic problems were identified; the most common were overtreatment, side effects, and administration difficulties. Recommendations often involved dose reduction or tapering, and about 75% were fully or partially implemented. Both participants and clinicians reported high satisfaction with shared decision-making. Multidisciplinary, structured medication reviews, incorporating accessible medication leaflets, may enhance appropriate medication use and shared decision-making, but more research is needed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Mental Healthcare Drenthe, Department Centre for Intellectual Disability and Mental Health, Middenweg 19, 9404 LL Assen, The Netherlands.
- Wilhelmina Hospital Assen, Department Pharmacy, 9401 RK Assen, The Netherlands.
ORCID-Profile: Gerda de Kuijper, Josien Jonker
Förderung
- Zorgondersteuningsfonds, P. O. box 169, 37ZK Soesterberg,
Zitieren
APA
de Kuijper, G., Jonker, J., & Hoge, R. (2026). Structured Medication Review and Shared Decision-Making in Patients with Mild Intellectual Disabilities Who Use Psychotropic Medication. Pharmacy, 14(1), 5. https://doi.org/10.3390/pharmacy14010005
Vancouver
de Kuijper G, Jonker J, Hoge R. Structured Medication Review and Shared Decision-Making in Patients with Mild Intellectual Disabilities Who Use Psychotropic Medication. Pharmacy. 2026;14(1):5. doi:10.3390/pharmacy14010005
BibTeX
@article{deKuijper2026,
author = {de Kuijper, Gerda and Jonker, Josien and Hoge, Rien},
title = {Structured Medication Review and Shared Decision-Making in Patients with Mild Intellectual Disabilities Who Use Psychotropic Medication},
journal = {Pharmacy},
year = {2026},
volume = {14},
number = {1},
pages = {5},
doi = {10.3390/pharmacy14010005}
}
EUVIMED